Valion Bio, Inc. (VBIO)
2.50
-0.27
(-9.75%)
USD |
NASDAQ |
Sep 08, 16:00
2.45
-0.05
(-2.00%)
Pre-Market: 08:41
Valion Bio Market Cap : 0.4153M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.4153M |
| September 04, 2026 | 0.4601M |
| September 03, 2026 | 0.4651M |
| September 02, 2026 | 0.5182M |
| September 01, 2026 | 0.5099M |
| August 31, 2026 | 0.593M |
| August 28, 2026 | 0.502M |
| August 27, 2026 | 0.5091M |
| August 26, 2026 | 0.6478M |
| August 25, 2026 | 16.50M |
| August 24, 2026 | 17.23M |
| August 21, 2026 | 12.73M |
| August 20, 2026 | 12.67M |
| August 19, 2026 | 13.95M |
| August 18, 2026 | 16.67M |
| August 17, 2026 | 18.94M |
| August 14, 2026 | 19.78M |
| August 13, 2026 | 17.73M |
| August 12, 2026 | 23.46M |
| August 11, 2026 | 32.18M |
| August 10, 2026 | 29.89M |
| August 07, 2026 | 29.62M |
| August 06, 2026 | 28.53M |
| August 05, 2026 | 30.36M |
| August 04, 2026 | 34.49M |
| Date | Value |
|---|---|
| August 03, 2026 | 32.80M |
| July 31, 2026 | 32.18M |
| July 30, 2026 | 28.86M |
| July 29, 2026 | 29.06M |
| July 28, 2026 | 29.87M |
| July 27, 2026 | 29.34M |
| July 24, 2026 | 30.83M |
| July 23, 2026 | 29.69M |
| July 22, 2026 | 29.58M |
| July 21, 2026 | 32.28M |
| July 20, 2026 | 37.48M |
| July 17, 2026 | 52.42M |
| July 16, 2026 | 50.69M |
| July 15, 2026 | 46.81M |
| July 14, 2026 | 48.70M |
| July 13, 2026 | 52.73M |
| July 10, 2026 | 52.83M |
| July 09, 2026 | 51.90M |
| July 08, 2026 | 50.86M |
| July 07, 2026 | 53.20M |
| July 06, 2026 | 52.79M |
| July 02, 2026 | 51.78M |
| July 01, 2026 | 53.82M |
| June 30, 2026 | 53.96M |
| June 29, 2026 | 39.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Outlook Therapeutics, Inc. | 119.84M |
| Agenus, Inc. | 316.63M |
| Amgen, Inc. | 212.55B |
| Anika Therapeutics, Inc. | 281.58M |
| BioCryst Pharmaceuticals, Inc. | 2.314B |
Market Cap Related Metrics
| PS Ratio | 1.450 |
| Price to Book Value | 0.0978 |
| Price | 2.50 |
| Earnings Yield | -8.41K% |